H-D-Gln(Trt)-OH

H-D-Gln(Trt)-OH is a protected, deuterated glutamine derivative in which the α-amino group is present as an N-deuterated (H-D) functionality and the side-chain amide of glutamine is retained, while the side-chain nitrogen is protected as a trityl (Trt) group. The molecule contains a free carboxylic acid (-COOH) and an amide-bearing side chain, with the Trt protecting group increasing chemoselectivity by reducing undesired side reactions during peptide-coupling steps. H-D-Gln(Trt)-OH is used as a stepwise building block for peptide synthesis and as a chemically defined, isotopically labeled amino acid analogue for studies requiring deuterium incorporation in glutamine-containing sequences or analytical method development.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP26662

CAS No:200625-76-9

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C24H24N2O3
M.W/Mr.
388.47

H-D-Gln(Trt)-OH is a protected, stereochemically defined amino acid derivative featuring a D-configured glutamine backbone with an N-terminal amino group blocked as a free amine under the H- notation and a side chain bearing a carboxamide functionality masked through Trt (trityl) protection strategy. The molecule contains the characteristic amino acid core with a carboxylic acid at the C-terminus, enabling direct participation in peptide coupling chemistry while the Trt-protected side-chain amide is engineered to suppress undesired side reactions during synthesis. The Trt group introduces a bulky, acid-labile protecting motif that can be removed under controlled conditions to regenerate the glutamine side-chain amide for subsequent biological or synthetic transformations. The presence of both a reactive carboxylic acid and a protected side-chain functionality makes H-D-Gln(Trt)-OH a chiral, peptide-compatible intermediate for building D-amino acid containing sequences and for downstream derivatization where controlled exposure of the side-chain amide is required.

1. Peptide Synthesis

H-D-Gln(Trt)-OH is used in peptide synthesis workflows where D-glutamine incorporation is targeted to modulate backbone stereochemistry and proteolytic stability profiles. The carboxylic acid and amino functionality support standard peptide coupling approaches, while the Trt-protected side-chain carboxamide reduces competing acylation or side-chain reactivity during chain assembly. The D-configuration at the glutamine stereocenter enables construction of D-amino acid rich segments that can be carried through iterative coupling cycles without premature side-chain exposure. After side-chain deprotection, the regenerated glutamine amide can participate in hydrogen bonding patterns that influence folding and molecular recognition in peptide analogs, making the compound suitable for peptide building block preparation in synthetic peptide chemistry and related process development.

2. Protected Amino Acids

H-D-Gln(Trt)-OH functions as a protected amino acid derivative for chemoselective synthesis planning in which side-chain protection and staged deprotection are required. The Trt group provides steric shielding and acid-labile behavior for the glutamine side-chain amide, allowing the amino acid to remain chemically well-behaved during N- and C-terminal functionalization steps. The free C-terminal carboxylic acid supports conversion to activated acyl species or coupling-ready forms, while the protected side chain prevents uncontrolled formation of side products that can arise from unprotected amide nucleophilicity. This design aligns with protected amino acid synthesis strategies used to prepare D-amino acid containing intermediates for iterative peptide construction and for generating defined stereochemical variants in fine chemical manufacturing.

3. Chemical Biology Studies

H-D-Gln(Trt)-OH is applied in chemical biology research to generate D-glutamine-containing peptide probes and protein-modifying reagents where side-chain amide presentation must be controlled. The glutamine side chain provides a hydrogen-bonding acceptor site that can be unmasked by Trt removal to enable defined interactions in biochemical assays or binding studies. The D-amino acid backbone can be incorporated to tune conformational preferences and resistance to enzymatic degradation, supporting mechanistic investigations that rely on stable analogs rather than rapidly metabolized substrates. The compound's peptide-compatible functionality enables incorporation into labeled or functionalized sequences used for studying molecular recognition, substrate specificity, and interaction networks, linking amino acid derivatization chemistry to downstream biochemical probe generation.

4. Bioconjugation Chemistry

H-D-Gln(Trt)-OH is suitable for bioconjugation chemistry when D-glutamine residues are required as structural elements in conjugates that include peptides, linkers, or biomolecule-targeting scaffolds. The protected side-chain carboxamide can be deprotected to provide a defined amide functionality that participates in hydrogen-bonding-driven positioning within conjugate architectures. The carboxylic acid enables attachment strategies that integrate the amino acid into peptide linkers preceding conjugation to proteins, polymers, or other biomolecular carriers. Controlled deprotection of the Trt group supports stepwise assembly where reactive sites are generated only when needed, supporting reliable downstream formation of defined conjugate structures used in applied biochemical research and specialty chemical production.

5. Pharmaceutical Manufacturing

H-D-Gln(Trt)-OH can be employed in pharmaceutical manufacturing settings for the preparation of stereochemically defined peptide intermediates and D-amino acid containing building blocks used in process chemistry. The acid-labile Trt protection strategy supports manufacturing-compatible protection/deprotection sequences that help manage side-chain reactivity during coupling and purification steps. The presence of a C-terminal carboxylic acid enables integration into manufacturing routes that convert amino acid derivatives into activated intermediates for controlled peptide assembly. The D-configured glutamine core supports the production of peptide analogs with defined stereochemical composition for analytical characterization and downstream formulation work in industrial peptide and fine chemical manufacturing environments.

6. Peptidomimetics And SAR

H-D-Gln(Trt)-OH serves as a chiral amino acid intermediate for peptidomimetic construction and structure-activity relationship studies where glutamine-like side-chain interactions must be preserved under stereochemical variation. The side-chain amide, protected as Trt during synthesis, can be revealed to reproduce key hydrogen-bonding features that influence binding motifs in SAR libraries. The D-configuration supports systematic exploration of stereochemical effects on conformation and target engagement while maintaining a glutamine-derived functional group pattern. Incorporation into peptide analog scaffolds enables generation of defined stereoisomer series for synthetic methodology development, fragment-based molecular design, and iterative optimization of amino acid based constructs used in applied discovery and industrial fine chemical synthesis.

Size
1 g;5 g;

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicePeptide Modification ServicescGMP Peptide ServicePeptide Synthesis ServicesPeptide Analysis ServicesPeptide Nucleic Acids SynthesisEpitope Mapping ServicesPeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers